Zum Inhalt springen
Home » COUR Pharmaceuticals Appoints Tim Walbert to its Board of Directors

COUR Pharmaceuticals Appoints Tim Walbert to its Board of Directors

Former Horizon Therapeutics CEO adds valuable expertise in the discovery, development, and commercialization of treatments for autoimmune and inflammatory diseases Former Horizon Therapeutics CEO adds valuable expertise in the discovery, development, and commercialization of treatments for autoimmune and inflammatory diseases The post COUR Pharmaceuticals Appoints Tim Walbert to its Board of Directors appeared first on…

COUR Pharmaceuticals Appoints Tim Walbert to its Board of Directors